î
îŒ
ãã°ã€ã³
î
Neurosense Therapeutics Ltd
NRSNW0.200USD
+0.040+25.00%
ååŒæé ïŒETïŒ15åé
ãã®æ ªäŸ¡
0.00æ䟡ç·é¡
--çŽè¿12ã¶æPER
î
詳现æ å ± Neurosense Therapeutics Ltd äŒæ¥å
NeuroSense Therapeutics Ltd is an Israel-based clinical-stage pharmaceutical company. The Company is active in field of drug development and treatment offers Amyotrophic Lateral Sclerosis (ALS) patients, as well as other neurodegenerative diseases. The Company's lead product candidate, PrimeC, is an oral formulation of a fixed dose combination composed of a specific ratio of drugs. In addition to PrimeC, the Company has initiated research and development efforts in Alzheimer's disease and Parkinson's disease
Neurosense Therapeutics Ltdã®äŒæ¥æ å ±
îäŒæ¥ã³ãŒãNRSNW
äŒç€ŸåNeurosense Therapeutics Ltd
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Alon Ben-Noon
åŸæ¥å¡æ°- -
蚌åžçš®é¡Company Warrant
決ç®ææ«- -
æ¬ç€Ÿæåšå°11 Hamenofim St.
éœåžHERZLIYA
蚌åžååŒæNASDAQ Capital Market Consolidated
åœIsrael
éµäŸ¿çªå·4672562
é»è©±çªå·97299531142
ãŠã§ããµã€ãhttps://www.neurosense-tx.com/
äŒæ¥ã³ãŒãNRSNW
äžå Žæ¥Dec 09, 2021
æé«çµå¶è²¬ä»»è
ãCEOãMr. Alon Ben-Noon
Neurosense Therapeutics Ltdã®çµå¶é£
îäŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Ms. Caren Deardorf
Ms. Caren Deardorf
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Dr. Revital Mandil-Levin, Ph.D.
Dr. Revital Mandil-Levin, Ph.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
äŒç€Ÿå
äŒç€Ÿå/ããžã·ã§ã³
ããžã·ã§ã³
æ ªåŒä¿æ
å€åé¡
Ms. Christine A. Pellizzari, J.D.
Ms. Christine A. Pellizzari, J.D.
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Mark W. Leuchtenberger
Mr. Mark W. Leuchtenberger
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Alon Ben-Noon
Mr. Alon Ben-Noon
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Mr. Or Eisenberg
Mr. Or Eisenberg
Chief Financial Officer
Chief Financial Officer
--
--
Dr. Ferenc Tracik
Dr. Ferenc Tracik
Chief Medical Officer
Chief Medical Officer
--
--
Mr. Cary J. Claiborne
Mr. Cary J. Claiborne
Non-Executive Independent Director
Non-Executive Independent Director
--
--
åçå èš³
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
äºæ¥å¥
å°åå¥
äŒç€Ÿããé¢é£ããŒã¿ããŸã é瀺ãããŠããŸããã
æ ªäž»
æŽæ°æå»: Fri, Feb 13
æŽæ°æå»: Fri, Feb 13
æ ªäž»çµ±èš
çš®é¡
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ ªäž»çµ±èš
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
çš®é¡
æ ªäž»çµ±èš
æ¯ç
ä»ã®
100.00%
æ©é¢æè³å®¶ä¿ææ ª
îæŽæ°æå»: Wed, Jan 21
æŽæ°æå»: Wed, Jan 21
å ±åæé
æ©é¢æè³å®¶æ°
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
2026Q4
5
128.65K
0.00%
--
2025Q4
6
128.53K
0.00%
-57.97K
2025Q3
6
65.16K
0.00%
-123.11K
2025Q2
6
78.60K
0.00%
-114.75K
2025Q1
6
78.60K
0.00%
-114.75K
2024Q4
6
106.40K
0.00%
-91.99K
2024Q3
6
111.43K
0.00%
-96.87K
2024Q2
7
281.35K
0.00%
-114.32K
2024Q1
7
395.47K
0.00%
+21.94K
2023Q4
7
369.53K
0.00%
-28.20K
詳现ãèŠã
æ ªäž»åå
îäŒç€Ÿå
ä¿ææ ªåŒæ°
æ¯ç
å€åé¡
å€åç
æ¥ä»
Clear Street LLC
63.69K
0%
-2.07K
-3.15%
Jun 30, 2025
Citadel Advisors LLC
--
0%
-22.71K
-100.00%
Mar 31, 2025
Warberg Asset Management LLC
--
0%
-10.00K
-100.00%
Jun 30, 2025
UBS Financial Services, Inc.
1.28K
0%
-190.00
-12.93%
Sep 30, 2025
Hudson Bay Capital Management LP
--
0%
-86.75K
-100.00%
Jun 30, 2024
Clear Street Group Inc
63.69K
0%
+63.69K
--
Sep 30, 2025
詳现ãèŠã
é¢é£ETF
îéæå
æ¯ç
ããŒã¿ãªã
é åœé
îéå»5幎éã®é
åœéç·æ¯æé¡ã¯
0.00
ç±³ãã«ã§ããã
æ¥ä»
é
åœé
æš©å©ç¢ºå®æ¥
æ¯ææ¥
é
åœèœã¡æ¥
ããŒã¿ãªã
æ ªåŒåå²
îæ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
æ¥ä»
é
åœèœã¡æ¥
çš®é¡
æ¯ç
ããŒã¿ãªã
